162 related articles for article (PubMed ID: 35817563)
21. Management of Pathogenic CDH1 Variant Carriers Within the FREGAT Network: A Multicentric Retrospective Study.
Bres C; Voron T; Benhaim L; Bergeat D; Parc Y; Karoui M; Genser L; Péré G; Demma JA; Bacoeur-Ouzillou O; Lebreton G; Thereaux J; Gronnier C; Dartigues P; Svrcek M; Bouzillé G; Bardier A; Brunac AC; Roche B; Darcha C; Bazille C; Doucet L; Belleannee G; Lejeune S; Buisine MP; Renaud F; Nuytens F; Benusiglio PR; Veziant J; Eveno C; Piessen G
Ann Surg; 2022 Nov; 276(5):830-837. PubMed ID: 35856494
[TBL] [Abstract][Full Text] [Related]
22. Enhanced endoscopic detection of occult gastric cancer in carriers of pathogenic CDH1 variants.
Curtin BF; Gamble LA; Schueler SA; Ruff SM; Quezado M; Miettinen M; Fasaye GA; Passi M; Hernandez JM; Heller T; Koh C; Davis JL
J Gastroenterol; 2021 Feb; 56(2):139-146. PubMed ID: 33206267
[TBL] [Abstract][Full Text] [Related]
23. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?
Chun YS; Lindor NM; Smyrk TC; Petersen BT; Burgart LJ; Guilford PJ; Donohue JH
Cancer; 2001 Jul; 92(1):181-7. PubMed ID: 11443625
[TBL] [Abstract][Full Text] [Related]
24. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
[TBL] [Abstract][Full Text] [Related]
25. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy after prophylactic total gastrectomy.
Kaurah P; Fitzgerald R; Dwerryhouse S; Huntsman DG
Fam Cancer; 2010 Sep; 9(3):331-4. PubMed ID: 20063069
[TBL] [Abstract][Full Text] [Related]
28. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?
Zhang Q; Yang Z; Karamchandani DM
Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations.
Laszkowska M; Tang L; Vos E; King S; Salo-Mullen E; Magahis PT; Abate M; Catchings A; Zauber AG; Hahn AI; Schattner M; Coit D; Stadler ZK; Strong VE; Markowitz AJ
Gastrointest Endosc; 2023 Sep; 98(3):326-336.e3. PubMed ID: 37094689
[TBL] [Abstract][Full Text] [Related]
30. Overview on new progress of hereditary diffuse gastric cancer with
Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
[TBL] [Abstract][Full Text] [Related]
31. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
[TBL] [Abstract][Full Text] [Related]
32. Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?
Munitiz Ruiz V; Jimeno P; Ruiz de Angulo D; Ortiz Á; Martínez de Haro LF; Marín M; Cascales P; Ruiz García G; Ortiz Ruiz E; Parrilla P
Rev Esp Enferm Dig; 2019 Mar; 111(3):189-192. PubMed ID: 30466290
[TBL] [Abstract][Full Text] [Related]
33. International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study.
Roberts G; Benusiglio PR; Bisseling T; Coit D; Davis JL; Grimes S; Guise TA; Hardwick R; Harris K; Mansfield PF; Rossaak J; Schreiber KC; Stanich PP; Strong VE; Kaurah P;
Gastric Cancer; 2022 Nov; 25(6):1094-1104. PubMed ID: 35831514
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic gastrectomy in a 16-year-old.
Wickremeratne T; Lee CH; Kirk J; Charlton A; Thomas G; Gaskin KJ
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):353-6. PubMed ID: 24240619
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic total gastrectomy for individuals with germline CDH1 mutation.
Pandalai PK; Lauwers GY; Chung DC; Patel D; Yoon SS
Surgery; 2011 Mar; 149(3):347-55. PubMed ID: 20719348
[TBL] [Abstract][Full Text] [Related]
37. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
van der Kaaij RT; van Kessel JP; van Dieren JM; Snaebjornsson P; Balagué O; van Coevorden F; van der Kolk LE; Sikorska K; Cats A; van Sandick JW
Br J Surg; 2018 Jan; 105(2):e176-e182. PubMed ID: 29341148
[TBL] [Abstract][Full Text] [Related]
38. CDH1 associated gastric cancer: a report of a family and review of the literature.
Moran CJ; Joyce M; McAnena OJ
Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
[TBL] [Abstract][Full Text] [Related]
39. Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy.
Gallanis AF; Gamble LA; Samaranayake SG; Lopez R; Rhodes A; Rajasimhan S; Fasaye GA; Juma O; Connolly M; Joyce S; Berger A; Heller T; Blakely AM; Hernandez JM; Davis JL
J Clin Oncol; 2024 Feb; 42(4):421-430. PubMed ID: 37903316
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study.
Bardram L; Hansen TV; Gerdes AM; Timshel S; Friis-Hansen L; Federspiel B
Fam Cancer; 2014 Jun; 13(2):231-42. PubMed ID: 24389957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
